首页 > 最新文献

American Journal of the Medical Sciences最新文献

英文 中文
Clotting without cause – unmasking IVC stenosis in a case of bilateral pulmonary emboli 无因凝血揭露双侧肺栓塞下腔静脉狭窄1例
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.030
R Dies, FS Mohiuddin, GK Eaves, A Lapointe, S Sanne, H Oddo Moise, A Pinner

Case Report

Introduction: Venous thromboembolism (VTE) and pulmonary embolism (PE) in young adults are frequently associated with hereditary thrombophilia, autoimmune disease, and malignancy. Advances in imaging have allowed for identification of inferior vena cava (IVC) anomalies as another etiology. Observational data indicates that congenital inferior vena cava (IVC) anomalies are quite rare but are associated with as much as a 50-100-fold increase in risk for deep venous thrombosis (DVT). Even more worrisome is the propensity for subsequent PE.
Case: A 30-year-old male with tobacco use disorder presented with two weeks of worsening pleuritic chest pain and dyspnea on exertion, as well as an episode of hemoptysis with clot expectoration. An electrocardiogram showed sinus tachycardia, a rightward axis, and an S1Q3T3 pattern. Computed tomography (CT) imaging of the pulmonary arteries revealed bilateral segmental and subsegmental pulmonary emboli, and he was started on a heparin infusion. Bilateral lower extremity ultrasounds revealed no thrombus, however, given his young age without provoking factors, a CT of his abdomen and pelvis was obtained. Findings demonstrated what appeared to be complete occlusion of the IVC, with extension into the iliac vessels and reconstitution of hepatic IVC, suprahepatic IVC, and hemiazygos veins via collaterals appreciated. A venogram revealed a stenosis of the intrahepatic IVC with no visualized thrombus. After an extensive hypercoagulability workup was unremarkable, he was discharged on apixaban with plans to perform an outpatient intravenous ultrasound (IVUS). He was lost to follow-up and, due to lack of insurance, had difficulty affording his anticoagulant. He presented again several months later with two days of acute leg pain and swelling to his right lower extremity. Ultrasonography revealed an occlusive thrombus in the common femoral, greater saphenous, superficial femoral, and profunda veins requiring thrombectomy. Testing for echinococcus was negative.

Discussion

Congenital IVC stenosis is a rare cause of VTE in young adults and is usually discovered when evaluating a proximal DVT in the absence of thrombophilia, autoimmune disease, or malignancy. Even more rarely, it may manifest itself via PE. Recognition is critical, as delayed diagnosis increases the risk of recurrence and post-thrombotic complications. Even with formation of collaterals, the resultant stasis from inadequate blood flow past the lesion can predispose to proximal DVT. This case highlights the importance of considering central venous anomalies in unexplained VTE and PE in young adults without other risk factors and underscores the role of dedicated imaging for diagnosis. Anticoagulation remains first-line therapy for thrombosis and select patients may be chosen to undergo endovascular stenting, as balloon angioplasty is often insufficient.
病例报告简介:年轻成人的静脉血栓栓塞(VTE)和肺栓塞(PE)通常与遗传性血栓病、自身免疫性疾病和恶性肿瘤有关。影像学的进步使得下腔静脉(IVC)异常作为另一种病因得以识别。观察数据表明,先天性下腔静脉(IVC)异常非常罕见,但与深静脉血栓形成(DVT)的风险增加多达50-100倍相关。更令人担忧的是后续PE的倾向。病例:一名30岁男性吸烟障碍患者,两周后胸膜炎性胸痛加重,用力时呼吸困难,咯血伴血块咳痰。心电图显示窦性心动过速,向右轴,S1Q3T3型。肺动脉的计算机断层扫描(CT)显示双节段性和亚节段性肺栓塞,他开始接受肝素输注。双侧下肢超声检查未发现血栓,但考虑到患者年龄小,无诱发因素,对其腹部和骨盆进行了CT检查。结果显示下腔静脉完全闭塞,延伸至髂血管,肝下腔静脉、肝上下腔静脉和半奇静脉经侧枝重建。静脉造影显示肝内静脉狭窄,未见血栓。在进行了广泛的高凝检查后,他被允许使用阿哌沙班出院,并计划进行门诊静脉超声检查(IVUS)。他失去了随访,由于缺乏保险,他很难负担抗凝血剂。几个月后,他再次出现两天的急性腿部疼痛和右下肢肿胀。超声检查显示在股总静脉、大隐静脉、股浅静脉和股深静脉有闭塞血栓,需要取栓。棘球蚴检测呈阴性。先天性下腔静脉狭窄在年轻人中是一种罕见的静脉血栓栓塞的病因,通常在没有血栓形成、自身免疫性疾病或恶性肿瘤的情况下,在评估近端静脉血栓栓塞时发现。更罕见的是,它可能通过PE表现出来。识别是至关重要的,因为延迟诊断会增加复发和血栓后并发症的风险。即使有了络的形成,通过病变的血流量不足所导致的瘀血也容易导致近端DVT。本病例强调了在没有其他危险因素的年轻人中,在不明原因的静脉血栓栓塞和血栓栓塞中考虑中心静脉异常的重要性,并强调了专用影像学诊断的作用。抗凝仍然是治疗血栓形成的一线治疗方法,由于球囊血管成形术往往不够,部分患者可以选择接受血管内支架植入术。
{"title":"Clotting without cause – unmasking IVC stenosis in a case of bilateral pulmonary emboli","authors":"R Dies,&nbsp;FS Mohiuddin,&nbsp;GK Eaves,&nbsp;A Lapointe,&nbsp;S Sanne,&nbsp;H Oddo Moise,&nbsp;A Pinner","doi":"10.1016/j.amjms.2025.12.030","DOIUrl":"10.1016/j.amjms.2025.12.030","url":null,"abstract":"<div><h3>Case Report</h3><div>Introduction: Venous thromboembolism (VTE) and pulmonary embolism (PE) in young adults are frequently associated with hereditary thrombophilia, autoimmune disease, and malignancy. Advances in imaging have allowed for identification of inferior vena cava (IVC) anomalies as another etiology. Observational data indicates that congenital inferior vena cava (IVC) anomalies are quite rare but are associated with as much as a 50-100-fold increase in risk for deep venous thrombosis (DVT). Even more worrisome is the propensity for subsequent PE.</div><div>Case: A 30-year-old male with tobacco use disorder presented with two weeks of worsening pleuritic chest pain and dyspnea on exertion, as well as an episode of hemoptysis with clot expectoration. An electrocardiogram showed sinus tachycardia, a rightward axis, and an S1Q3T3 pattern. Computed tomography (CT) imaging of the pulmonary arteries revealed bilateral segmental and subsegmental pulmonary emboli, and he was started on a heparin infusion. Bilateral lower extremity ultrasounds revealed no thrombus, however, given his young age without provoking factors, a CT of his abdomen and pelvis was obtained. Findings demonstrated what appeared to be complete occlusion of the IVC, with extension into the iliac vessels and reconstitution of hepatic IVC, suprahepatic IVC, and hemiazygos veins via collaterals appreciated. A venogram revealed a stenosis of the intrahepatic IVC with no visualized thrombus. After an extensive hypercoagulability workup was unremarkable, he was discharged on apixaban with plans to perform an outpatient intravenous ultrasound (IVUS). He was lost to follow-up and, due to lack of insurance, had difficulty affording his anticoagulant. He presented again several months later with two days of acute leg pain and swelling to his right lower extremity. Ultrasonography revealed an occlusive thrombus in the common femoral, greater saphenous, superficial femoral, and profunda veins requiring thrombectomy. Testing for echinococcus was negative.</div></div><div><h3>Discussion</h3><div>Congenital IVC stenosis is a rare cause of VTE in young adults and is usually discovered when evaluating a proximal DVT in the absence of thrombophilia, autoimmune disease, or malignancy. Even more rarely, it may manifest itself via PE. Recognition is critical, as delayed diagnosis increases the risk of recurrence and post-thrombotic complications. Even with formation of collaterals, the resultant stasis from inadequate blood flow past the lesion can predispose to proximal DVT. This case highlights the importance of considering central venous anomalies in unexplained VTE and PE in young adults without other risk factors and underscores the role of dedicated imaging for diagnosis. Anticoagulation remains first-line therapy for thrombosis and select patients may be chosen to undergo endovascular stenting, as balloon angioplasty is often insufficient.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Pages S16-S17"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colovesical fistula in a young patient: a diagnostic delay 膀胱瘘的年轻患者:诊断延迟
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.037
R Kumar, Y Santharam, B Woodbeck, S Parekh, N Qadir, P Reddy
<div><h3>Case Report</h3><div>A colovesical fistula is an abnormal epithelialized tract between the colon and bladder that allows the passage of gas or fecal material into the urinary tract. It is an uncommon presentation, often seen in older patients. As such, the diagnosis in younger individuals is often missed or delayed, particularly in those without known colonic disease.</div><div>A 38-year-old male presented with a one-month history of dysuria, urinary frequency, and hematuria. Initial workup showed a negative sexually transmitted infection (STI) panel and mixed flora on urine culture. Due to high suspicion for prostatitis, he was treated empirically with a four-week course of ciprofloxacin and tamsulosin. One month later, he returned with persistent symptoms, now accompanied by suprapubic pain and dark urine containing visible sediment. Bladder ultrasound showed circumferential wall thickening and intraluminal debris without hydronephrosis. Urine cultures returned negative, and he was discharged on a 10-day course of trimethoprim-sulfamethoxazole for presumed cystitis. One month later, he presented a third time with ongoing urinary complaints. At this time, computed tomography (CT) of the abdomen and pelvis revealed stool and air within the bladder, highly concerning for a colovesical fistula <strong><em>(Figure 1)</em></strong>. Additional magnetic resonance imaging (MRI) of the pelvis demonstrated a 6.1 × 4.6 cm abscess from perforated sigmoid diverticulitis, with a fistulous connection to the bladder. Given his age, the possible etiologies included inflammatory bowel disease (IBD) and diverticulitis. He was started on broad-spectrum intravenous antibiotics and octreotide to reduce fistula output. Laboratory studies revealed elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), with a markedly elevated fecal calprotectin. IBD-associated antibodies (p-ANCA and ASCA), enteric pathogen testing, and blood cultures, were negative. Definitive management included robotic-assisted Hartmann's procedure and incision and drainage of the abdominal wall abscess. Histopathology of the resected sigmoid colon confirmed diverticulitis as the etiology. At follow-up, the patient reported resolution of fecaluria, minimal urinary symptoms, and ongoing plans for ostomy reversal.</div><div>This case highlights the diagnostic difficulty of colovesical fistulas in younger patients, where urinary tract infections, nephrolithiasis, and STI's are often prioritized, delaying advanced imaging. Even when a fistula is identified, IBD is often suspected over diverticulitis. They remain rare in younger populations, with studies identifying a mean age of 58.1 years, with only a minority younger than 40. Despite three emergency department visits, the diagnosis was not established in our 38-year-old patient until CT imaging was obtained. Recurrent urinary infections, persistent sediment, or pneumaturia should prompt suspicion and early imaging to redu
膀胱瘘是介于结肠和膀胱之间的一种异常上皮化的管道,它允许气体或粪便物质进入尿道。这是一种罕见的表现,常见于老年患者。因此,年轻人的诊断经常被遗漏或延迟,特别是那些没有已知结肠疾病的人。38岁男性,有1个月的排尿困难、尿频和血尿病史。初步检查显示性传播感染(STI)阴性,尿液培养菌群混合。由于对前列腺炎的高度怀疑,他接受了为期四周的环丙沙星和坦索罗辛的经验治疗。一个月后,他再次出现持续症状,现在伴有耻骨上疼痛和含有可见沉淀物的深色尿液。膀胱超声示周壁增厚及腔内碎片,无肾积水。尿培养呈阴性,患者因疑似膀胱炎接受10天的甲氧苄啶-磺胺甲恶唑治疗出院。一个月后,他第三次出现持续的泌尿系统疾病。此时,腹部和骨盆的计算机断层扫描(CT)显示膀胱内有粪便和空气,高度关注膀胱瘘(图1)。骨盆的额外磁共振成像(MRI)显示一个6.1 × 4.6 cm的乙状结肠憩室炎脓肿,与膀胱有瘘口连接。鉴于他的年龄,可能的病因包括炎症性肠病(IBD)和憩室炎。他开始使用广谱静脉注射抗生素和奥曲肽来减少瘘管输出。实验室研究显示红细胞沉降率(ESR)和c反应蛋白(CRP)升高,粪便钙保护蛋白明显升高。ibd相关抗体(p-ANCA和ASCA)、肠道病原体检测和血液培养均为阴性。最终的治疗包括机器人辅助哈特曼手术和腹壁脓肿的切开和引流。切除的乙状结肠组织病理学证实其病因为憩室炎。在随访中,患者报告粪尿缓解,泌尿系统症状最小,并且正在进行造口术逆转的计划。该病例强调了年轻患者膀胱瘘的诊断困难,他们通常优先考虑尿路感染、肾结石和性传播感染,从而延迟了晚期影像学检查。即使发现了瘘管,IBD也常被怀疑为憩室炎。他们在年轻人群中仍然很少见,研究发现平均年龄为58.1岁,只有少数人在40岁以下。尽管去了三次急诊科,但直到获得CT成像,我们才确定了38岁患者的诊断。复发性尿路感染、持续性沉淀物或肺炎应引起怀疑和早期影像学检查,以减少发病率并及时进行手术治疗。
{"title":"Colovesical fistula in a young patient: a diagnostic delay","authors":"R Kumar,&nbsp;Y Santharam,&nbsp;B Woodbeck,&nbsp;S Parekh,&nbsp;N Qadir,&nbsp;P Reddy","doi":"10.1016/j.amjms.2025.12.037","DOIUrl":"10.1016/j.amjms.2025.12.037","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Case Report&lt;/h3&gt;&lt;div&gt;A colovesical fistula is an abnormal epithelialized tract between the colon and bladder that allows the passage of gas or fecal material into the urinary tract. It is an uncommon presentation, often seen in older patients. As such, the diagnosis in younger individuals is often missed or delayed, particularly in those without known colonic disease.&lt;/div&gt;&lt;div&gt;A 38-year-old male presented with a one-month history of dysuria, urinary frequency, and hematuria. Initial workup showed a negative sexually transmitted infection (STI) panel and mixed flora on urine culture. Due to high suspicion for prostatitis, he was treated empirically with a four-week course of ciprofloxacin and tamsulosin. One month later, he returned with persistent symptoms, now accompanied by suprapubic pain and dark urine containing visible sediment. Bladder ultrasound showed circumferential wall thickening and intraluminal debris without hydronephrosis. Urine cultures returned negative, and he was discharged on a 10-day course of trimethoprim-sulfamethoxazole for presumed cystitis. One month later, he presented a third time with ongoing urinary complaints. At this time, computed tomography (CT) of the abdomen and pelvis revealed stool and air within the bladder, highly concerning for a colovesical fistula &lt;strong&gt;&lt;em&gt;(Figure 1)&lt;/em&gt;&lt;/strong&gt;. Additional magnetic resonance imaging (MRI) of the pelvis demonstrated a 6.1 × 4.6 cm abscess from perforated sigmoid diverticulitis, with a fistulous connection to the bladder. Given his age, the possible etiologies included inflammatory bowel disease (IBD) and diverticulitis. He was started on broad-spectrum intravenous antibiotics and octreotide to reduce fistula output. Laboratory studies revealed elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), with a markedly elevated fecal calprotectin. IBD-associated antibodies (p-ANCA and ASCA), enteric pathogen testing, and blood cultures, were negative. Definitive management included robotic-assisted Hartmann's procedure and incision and drainage of the abdominal wall abscess. Histopathology of the resected sigmoid colon confirmed diverticulitis as the etiology. At follow-up, the patient reported resolution of fecaluria, minimal urinary symptoms, and ongoing plans for ostomy reversal.&lt;/div&gt;&lt;div&gt;This case highlights the diagnostic difficulty of colovesical fistulas in younger patients, where urinary tract infections, nephrolithiasis, and STI's are often prioritized, delaying advanced imaging. Even when a fistula is identified, IBD is often suspected over diverticulitis. They remain rare in younger populations, with studies identifying a mean age of 58.1 years, with only a minority younger than 40. Despite three emergency department visits, the diagnosis was not established in our 38-year-old patient until CT imaging was obtained. Recurrent urinary infections, persistent sediment, or pneumaturia should prompt suspicion and early imaging to redu","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Pages S19-S20"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal ectopic Purkinje-related premature contractions: an uncommon genetic cause of syncope in a young woman 多灶异位浦肯病相关的早缩:一个不常见的遗传原因晕厥在一个年轻的女人
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.023
S Hubbard
<div><h3>Case Report</h3><div>A 20-year-old woman from Central America with no past medical history presented with progressive dyspnea, palpitations, and recurrent syncope. She first developed shortness of breath during pregnancy three years earlier, which she initially attributed to normal pregnancy changes, but her symptoms persisted and gradually worsened after delivery. She reported difficulty sleeping due to dyspnea, frequent palpitations, and experienced two episodes of sudden syncope with minimal exertion. Family history was notable for multiple relatives with arrhythmias and unexplained dyspnea.</div><div>EKG showed sinus rhythm with incomplete right bundle branch block, frequent atrial ectopy, and multifocal premature ventricular contractions. TTE revealed normal cardiac structure and function, while cardiac MRI and PET showed no evidence of myocarditis or infiltrative disease. Labs were unremarkable, including normal ESR/CRP, thyroid function, ferritin, and negative serologies for Chagas and Lyme disease.</div><div>Ambulatory monitoring demonstrated ∼6% PVC burden with episodes of nonsustained ventricular tachycardia. EP study demonstrated PVCs from multiple Purkinje-related sites, including the moderator band and papillary muscles. Ablation suppressed one focus, but recurrence from others occurred, and a repeat attempt was aborted. Genetic testing subsequently confirmed a pathogenic SCN5A variant consistent with Multifocal Ectopic Purkinje-Related Premature Contractions (MEPPC). She was started on flecainide, which led to significant symptomatic improvement. Given her recurrent syncope and elevated risk of malignant arrhythmias, she underwent primary prevention ICD implantation.</div><div>MEPPC is a rare inherited arrhythmia syndrome caused by mutations in the SCN5A sodium channel gene, which increase Purkinje fiber excitability and lead to multifocal PVCs. This can lead to recurrent syncope and risk of sudden cardiac death. Unlike focal PVCs that respond well to ablation, the diffuse Purkinje substrate in MEPPC makes ablation largely ineffective, as suppression of one site is often followed by recurrence elsewhere. Recognition of this distinction is critical to avoid repeated invasive procedures with limited benefit.</div><div>This case demonstrates the importance of broadening the differential diagnosis of syncope in young patients. The combination of multifocal ectopy and a suggestive family history should raise suspicion for a genetic arrhythmia syndrome. Genetic confirmation not only clarifies the diagnosis but also allows appropriate counseling, family screening, and individualized management. In this patient, it guided referral for ICD implantation and supported flecainide therapy, which directly suppressed the arrhythmic substrate.</div><div>In young patients with unexplained syncope and multifocal PVCs despite normal imaging, genetic arrhythmia syndromes such as MEPPC should be considered. Early recognition can prevent unneces
病例报告:一名来自中美洲的20岁女性,无既往病史,表现为进行性呼吸困难、心悸和复发性晕厥。她在三年前怀孕时首次出现呼吸短促,她最初认为这是正常的妊娠变化,但她的症状持续存在,并在分娩后逐渐恶化。她报告因呼吸困难、频繁心悸而难以入睡,并经历了两次突然晕厥,但用力很小。有多名亲属有心律失常和不明原因呼吸困难的家族史。心电图显示窦性心律伴不完全性右束支传导阻滞,频繁心房异位,多灶性室性早搏。TTE显示心脏结构和功能正常,而心脏MRI和PET未显示心肌炎或浸润性疾病。实验室检查无明显异常,包括ESR/CRP、甲状腺功能、铁蛋白正常,查加斯病和莱姆病血清学阴性。动态监测显示约6%的PVC负荷伴非持续性室性心动过速发作。EP研究显示,包括调节带和乳头肌在内的多个浦肯病相关部位出现了室性早搏。消融抑制了一个病灶,但发生了其他病灶的复发,再次尝试失败。随后,基因检测证实了一种与多灶异位性浦肯病相关早缩(MEPPC)一致的致病性SCN5A变异。她开始服用氟氯胺,导致症状明显改善。鉴于她的复发性晕厥和恶性心律失常的高风险,她接受了一级预防ICD植入。MEPPC是一种罕见的遗传性心律失常综合征,由SCN5A钠通道基因突变引起,可增加浦肯野纤维兴奋性,导致多灶性室性早搏。这可导致复发性晕厥和心源性猝死的风险。与灶性室性癌对消融反应良好不同,MEPPC中的弥漫性浦肯野基质使得消融在很大程度上无效,因为一个部位的抑制通常会导致其他部位的复发。认识到这一区别对于避免重复的侵入性手术是至关重要的。本病例表明扩大年轻患者晕厥鉴别诊断的重要性。多灶异位和家族史的结合应引起对遗传性心律失常综合征的怀疑。基因确认不仅可以明确诊断,还可以提供适当的咨询、家庭筛查和个性化管理。在该患者中,它指导转诊ICD植入,并支持氟氯胺治疗,直接抑制心律失常底物。年轻患者出现不明原因晕厥和多灶性室性早搏,尽管影像学正常,但应考虑遗传性心律失常综合征,如MEPPC。早期识别可以防止不必要的干预,指导有效的治疗,并及时进行家庭评估。
{"title":"Multifocal ectopic Purkinje-related premature contractions: an uncommon genetic cause of syncope in a young woman","authors":"S Hubbard","doi":"10.1016/j.amjms.2025.12.023","DOIUrl":"10.1016/j.amjms.2025.12.023","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Case Report&lt;/h3&gt;&lt;div&gt;A 20-year-old woman from Central America with no past medical history presented with progressive dyspnea, palpitations, and recurrent syncope. She first developed shortness of breath during pregnancy three years earlier, which she initially attributed to normal pregnancy changes, but her symptoms persisted and gradually worsened after delivery. She reported difficulty sleeping due to dyspnea, frequent palpitations, and experienced two episodes of sudden syncope with minimal exertion. Family history was notable for multiple relatives with arrhythmias and unexplained dyspnea.&lt;/div&gt;&lt;div&gt;EKG showed sinus rhythm with incomplete right bundle branch block, frequent atrial ectopy, and multifocal premature ventricular contractions. TTE revealed normal cardiac structure and function, while cardiac MRI and PET showed no evidence of myocarditis or infiltrative disease. Labs were unremarkable, including normal ESR/CRP, thyroid function, ferritin, and negative serologies for Chagas and Lyme disease.&lt;/div&gt;&lt;div&gt;Ambulatory monitoring demonstrated ∼6% PVC burden with episodes of nonsustained ventricular tachycardia. EP study demonstrated PVCs from multiple Purkinje-related sites, including the moderator band and papillary muscles. Ablation suppressed one focus, but recurrence from others occurred, and a repeat attempt was aborted. Genetic testing subsequently confirmed a pathogenic SCN5A variant consistent with Multifocal Ectopic Purkinje-Related Premature Contractions (MEPPC). She was started on flecainide, which led to significant symptomatic improvement. Given her recurrent syncope and elevated risk of malignant arrhythmias, she underwent primary prevention ICD implantation.&lt;/div&gt;&lt;div&gt;MEPPC is a rare inherited arrhythmia syndrome caused by mutations in the SCN5A sodium channel gene, which increase Purkinje fiber excitability and lead to multifocal PVCs. This can lead to recurrent syncope and risk of sudden cardiac death. Unlike focal PVCs that respond well to ablation, the diffuse Purkinje substrate in MEPPC makes ablation largely ineffective, as suppression of one site is often followed by recurrence elsewhere. Recognition of this distinction is critical to avoid repeated invasive procedures with limited benefit.&lt;/div&gt;&lt;div&gt;This case demonstrates the importance of broadening the differential diagnosis of syncope in young patients. The combination of multifocal ectopy and a suggestive family history should raise suspicion for a genetic arrhythmia syndrome. Genetic confirmation not only clarifies the diagnosis but also allows appropriate counseling, family screening, and individualized management. In this patient, it guided referral for ICD implantation and supported flecainide therapy, which directly suppressed the arrhythmic substrate.&lt;/div&gt;&lt;div&gt;In young patients with unexplained syncope and multifocal PVCs despite normal imaging, genetic arrhythmia syndromes such as MEPPC should be considered. Early recognition can prevent unneces","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Page S12"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salvage TIPS for massive GI bleed in a toddler 幼儿大量消化道出血的抢救TIPS
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.075
JC Nichols, S Patterson, R Kassel
<div><h3>Case Report</h3><div>Introduction: Portal vein thrombosis (PVT) is a rare complication of umbilical venous catheter (UVC) placement in neonates, with a mean incidence of 12%. While often asymptomatic, up to 27% progress to portal hypertension (HTN) or hepatic lobar atrophy. No standard screening exists. Transjugular intrahepatic portosystemic shunt (TIPS) is established management for acute variceal bleeding in adults, but pediatric data remain limited. We present a toddler with likely UVC-associated PVT who required emergent TIPS for variceal bleeding.</div></div><div><h3>Case Summary</h3><div>A 19-month-old female with VACTERL syndrome (including repaired tracheoesophageal fistula), prolonged NICU stay, radial hypoplasia, and unrepaired right aortic arch presented with acute hematemesis. EMS found her lethargic, hypoxic, and hypotensive. At a local hospital, hemoglobin (Hgb) was 3.9 and abdominal CT was unrevealing. She was resuscitated with fluids, blood products (platelets, fresh frozen plasma, and 2 units of red cells), and started on octreotide before transfer to our facility.</div><div>Upon arrival she was hemodynamically stable without further hematemesis, with Hgb 6.3, platelets 26, and a normal coagulation panel. Esophagogastroduodenoscopy (EGD) revealed esophageal varices without active bleeding. Ultrasound showed hepatosplenomegaly and many collateral vessels at the level of hepatic hilum, consistent with cavernous transformation of the portal vein.</div><div>On hospital day two massive hematemesis recurred with hemorrhagic shock. Bedside EGD with attempted variceal banding failed due to extent of bleeding, necessitating Blakemore tube placement and emergent TIPS. Hemostasis was achieved, but the procedure was complicated by a large hematoma and abdominal compartment syndrome requiring surgical decompression.</div><div>After delayed abdominal closure, titration of nasogastric tube feeds due to feeding intolerance, identification of oropharyngeal dysphagia, and supportive care of urinary retention the patient was discharged home. Repeat labs and imaging prior to discharge confirmed normal ammonia and patent TIPS. Coagulopathy work up was unrevealing. She has weaned off enteral feeds and long term portal HTN management planning is underway with gastroenterology.</div></div><div><h3>Discussion</h3><div>This case highlights the importance of maintaining a broad differential for acute GI bleeding in children. Hemorrhagic shock from variceal bleeding was the sentinel presentation of underlying portal HTN in this toddler, unmasking silent PVT with cavernous transformation in the setting of neonatal UVC. Emergent TIPS, though rarely performed in children, was lifesaving when endoscopic therapy failed, underscoring its potential role in pediatric acute variceal bleeding. The case also demonstrates the risks of TIPS, including hematoma and abdominal compartment syndrome.</div><div>Early recognition of PVT and portal HTN in at-risk pati
病例报告简介:门静脉血栓形成(PVT)是新生儿放置脐静脉导管(UVC)的罕见并发症,平均发病率为12%。虽然通常无症状,但高达27%的患者进展为门脉高压(HTN)或肝叶萎缩。没有标准的筛选存在。经颈静脉肝内门体分流术(TIPS)是成人急性静脉曲张出血的有效治疗方法,但儿科的相关数据仍然有限。我们报告了一个可能与uvc相关的PVT的幼儿,他需要紧急TIPS治疗静脉曲张出血。一例19月龄女性VACTERL综合征(包括气管食管瘘修复),NICU住院时间延长,桡骨发育不全,右主动脉弓未修复,出现急性呕血。急救发现她昏睡,缺氧,低血压。在当地医院,血红蛋白(Hgb)为3.9,腹部CT未显示。她接受了液体、血液制品(血小板、新鲜冷冻血浆和2单位红细胞)的复苏,并在转移到我们的设施之前开始使用奥曲肽。到达时,患者血流动力学稳定,无进一步吐血,血红蛋白6.3,血小板26,凝血功能正常。食管胃十二指肠镜检查显示食管静脉曲张,无活动性出血。超声示肝脾肿大,肝门部多侧支血管,符合门静脉海绵样变性。住院第2天再次出现大量吐血并失血性休克。床边EGD与尝试静脉曲张绑扎失败,由于出血的程度,需要布莱克摩尔管放置和紧急TIPS。止血是成功的,但手术是复杂的大血肿和腹腔隔室综合征需要手术减压。在延迟关闭腹部、因进食不耐受而进行鼻胃管喂养的滴定、口咽吞咽困难的鉴定和尿潴留的支持性护理后,患者出院回家。出院前重复实验室和影像学检查证实氨氮正常,TIPS专利。凝血功能不佳。她已经停止肠内喂养,胃肠病学正在进行长期的门户HTN管理计划。本病例强调了对儿童急性消化道出血保持广泛鉴别的重要性。静脉曲张出血引起的失血性休克是这名幼儿潜在门脉HTN的前哨表现,揭示了新生儿UVC背景下无症状的PVT伴海绵状转变。紧急TIPS虽然很少用于儿童,但在内窥镜治疗失败时可以挽救生命,这强调了其在儿童急性静脉曲张出血中的潜在作用。该病例也证明了TIPS的风险,包括血肿和腹腔隔室综合征。早期识别PVT和门脉HTN的高危患者可以防止灾难性的表现。当传统疗法不成功时,多学科管理是至关重要的。
{"title":"Salvage TIPS for massive GI bleed in a toddler","authors":"JC Nichols,&nbsp;S Patterson,&nbsp;R Kassel","doi":"10.1016/j.amjms.2025.12.075","DOIUrl":"10.1016/j.amjms.2025.12.075","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Case Report&lt;/h3&gt;&lt;div&gt;Introduction: Portal vein thrombosis (PVT) is a rare complication of umbilical venous catheter (UVC) placement in neonates, with a mean incidence of 12%. While often asymptomatic, up to 27% progress to portal hypertension (HTN) or hepatic lobar atrophy. No standard screening exists. Transjugular intrahepatic portosystemic shunt (TIPS) is established management for acute variceal bleeding in adults, but pediatric data remain limited. We present a toddler with likely UVC-associated PVT who required emergent TIPS for variceal bleeding.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Case Summary&lt;/h3&gt;&lt;div&gt;A 19-month-old female with VACTERL syndrome (including repaired tracheoesophageal fistula), prolonged NICU stay, radial hypoplasia, and unrepaired right aortic arch presented with acute hematemesis. EMS found her lethargic, hypoxic, and hypotensive. At a local hospital, hemoglobin (Hgb) was 3.9 and abdominal CT was unrevealing. She was resuscitated with fluids, blood products (platelets, fresh frozen plasma, and 2 units of red cells), and started on octreotide before transfer to our facility.&lt;/div&gt;&lt;div&gt;Upon arrival she was hemodynamically stable without further hematemesis, with Hgb 6.3, platelets 26, and a normal coagulation panel. Esophagogastroduodenoscopy (EGD) revealed esophageal varices without active bleeding. Ultrasound showed hepatosplenomegaly and many collateral vessels at the level of hepatic hilum, consistent with cavernous transformation of the portal vein.&lt;/div&gt;&lt;div&gt;On hospital day two massive hematemesis recurred with hemorrhagic shock. Bedside EGD with attempted variceal banding failed due to extent of bleeding, necessitating Blakemore tube placement and emergent TIPS. Hemostasis was achieved, but the procedure was complicated by a large hematoma and abdominal compartment syndrome requiring surgical decompression.&lt;/div&gt;&lt;div&gt;After delayed abdominal closure, titration of nasogastric tube feeds due to feeding intolerance, identification of oropharyngeal dysphagia, and supportive care of urinary retention the patient was discharged home. Repeat labs and imaging prior to discharge confirmed normal ammonia and patent TIPS. Coagulopathy work up was unrevealing. She has weaned off enteral feeds and long term portal HTN management planning is underway with gastroenterology.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Discussion&lt;/h3&gt;&lt;div&gt;This case highlights the importance of maintaining a broad differential for acute GI bleeding in children. Hemorrhagic shock from variceal bleeding was the sentinel presentation of underlying portal HTN in this toddler, unmasking silent PVT with cavernous transformation in the setting of neonatal UVC. Emergent TIPS, though rarely performed in children, was lifesaving when endoscopic therapy failed, underscoring its potential role in pediatric acute variceal bleeding. The case also demonstrates the risks of TIPS, including hematoma and abdominal compartment syndrome.&lt;/div&gt;&lt;div&gt;Early recognition of PVT and portal HTN in at-risk pati","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Pages S44-S45"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis 经导管三尖瓣置换术后高级别房室传导阻滞的发生率、预测因素和起搏器植入率:现实世界的分析
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.011
D Jadvani, N Ghanta, S Vallurupalli, T Bhupendar

Purpose

Transcatheter tricuspid valve replacement (TTVR) offers a reliable reduction of severe tricuspid regurgitation with a minimally invasive approach and improves quality of life. However, post-procedural conduction disturbances particularly high-grade atrioventricular nodal block (HAVB) remains a significant concern. Despite this, predictors of HAVB after TTVR remain poorly defined. We aimed to explore the incidence, risk factors, and clinical implications of HAVB.

Methods

Using TriNetX, a US collaborative database, we conducted a retrospective study on patients who underwent TTVR identified using relevant ICD-10-PCS codes (02RJ3JZ, 02RJ3KZ, 02RJ38Z, X2RJ3RA) and CPT code (0646T). Patients with prior heart transplant (ICD-10-CM Z94.1 / CPT 33945) or permanent pacemakers (ICD-10-CM Z95.0) were excluded. Two cohorts were defined: patients who developed HAVB within 1 month of TTVR vs those who did not at 1 month. Baseline demographic, clinical, and comorbidity data were extracted. Variables included age, sex, heart failure status, conduction system disease, renal function, and comorbid conditions. Outcomes of interest were the incidence of HAVB at 1 month, baseline predictors of this complication, and pacemaker implantation rate.

Results

Of the total 337 patients who underwent TTVR, 34 patients (10%) developed HAVB within a month post TTVR. Patients who developed HAVB were older (mean age 71.8 ± 13.3 vs 62.9 ± 18.8 years, p=0.01, SD 0.55) and hypertensive (84% VS 63%, p=0.0167, SD 0.50). The prevalence of end-stage renal disease was significantly higher in the HAVB group. Conduction system abnormalities (CSA): first-degree AV block, p=0.0002; left anterior fascicular block, p<0.0001; left bundle branch block, p<0.0001; persistent atrial fibrillation p=0.0112; atrial flutter p<0.0001, were disproportionately higher in the HAVB cohort. Importantly, 60% of patients with HAVB required pacemaker implantation within 30 days compared with 3.8% in the non-HAVB group (Risk Ratio 15.7, 95% CI 7.9–31.2, p<0.001).

Conclusions

In this real-world analysis of patients undergoing TTVR, 10% developed HDAVB within 1 month, and the majority required pacemaker implantation. Baseline CSAs emerged as significant risk factors. Large multicenter studies are needed to identify high risk patients in the peri-procedural planning of TTVR.
目的:经导管三尖瓣置换术(TTVR)是一种可靠的微创方法,可减少严重的三尖瓣反流,提高患者的生活质量。然而,手术后传导障碍,特别是高级别房室结阻滞(HAVB)仍然值得关注。尽管如此,TTVR后HAVB的预测指标仍然不明确。我们的目的是探讨HAVB的发病率、危险因素和临床意义。方法采用美国TriNetX合作数据库,对使用ICD-10-PCS相关代码(02RJ3JZ、02RJ3KZ、02RJ38Z、X2RJ3RA)和CPT代码(0646T)识别的TTVR患者进行回顾性研究。排除既往心脏移植(ICD-10-CM Z94.1 / CPT 33945)或永久性起搏器(ICD-10-CM Z95.0)患者。定义了两个队列:在TTVR后1个月内发生HAVB的患者和在1个月内没有发生HAVB的患者。提取基线人口统计学、临床和合并症数据。变量包括年龄、性别、心力衰竭状态、传导系统疾病、肾功能和合并症。关注的结果是1个月时HAVB的发生率、该并发症的基线预测指标和起搏器植入率。结果337例接受TTVR的患者中,34例(10%)在TTVR后1个月内发生HAVB。发生HAVB的患者年龄较大(平均年龄71.8±13.3岁vs 62.9±18.8岁,p=0.01, SD 0.55)和高血压(84% vs 63%, p=0.0167, SD 0.50)。终末期肾脏疾病的患病率在HAVB组明显更高。传导系统异常(CSA):一级房室传导阻滞,p=0.0002;左前束阻滞,p<0.0001;左束支块,p<0.0001;持续性房颤p=0.0112;心房扑动p<;0.0001,在HAVB队列中不成比例地高。重要的是,60%的HAVB患者在30天内需要植入起搏器,而非HAVB组为3.8%(风险比15.7,95% CI 7.9-31.2, p<0.001)。结论在对TTVR患者的现实分析中,10%的患者在1个月内发展为HDAVB,大多数患者需要植入起搏器。基线csa成为重要的风险因素。需要大规模的多中心研究来确定TTVR围手术期计划中的高危患者。
{"title":"Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis","authors":"D Jadvani,&nbsp;N Ghanta,&nbsp;S Vallurupalli,&nbsp;T Bhupendar","doi":"10.1016/j.amjms.2025.12.011","DOIUrl":"10.1016/j.amjms.2025.12.011","url":null,"abstract":"<div><h3>Purpose</h3><div>Transcatheter tricuspid valve replacement (TTVR) offers a reliable reduction of severe tricuspid regurgitation with a minimally invasive approach and improves quality of life. However, post-procedural conduction disturbances particularly high-grade atrioventricular nodal block (HAVB) remains a significant concern. Despite this, predictors of HAVB after TTVR remain poorly defined. We aimed to explore the incidence, risk factors, and clinical implications of HAVB.</div></div><div><h3>Methods</h3><div>Using TriNetX, a US collaborative database, we conducted a retrospective study on patients who underwent TTVR identified using relevant ICD-10-PCS codes (02RJ3JZ, 02RJ3KZ, 02RJ38Z, X2RJ3RA) and CPT code (0646T). Patients with prior heart transplant (ICD-10-CM Z94.1 / CPT 33945) or permanent pacemakers (ICD-10-CM Z95.0) were excluded. Two cohorts were defined: patients who developed HAVB within 1 month of TTVR vs those who did not at 1 month. Baseline demographic, clinical, and comorbidity data were extracted. Variables included age, sex, heart failure status, conduction system disease, renal function, and comorbid conditions. Outcomes of interest were the incidence of HAVB at 1 month, baseline predictors of this complication, and pacemaker implantation rate.</div></div><div><h3>Results</h3><div>Of the total 337 patients who underwent TTVR, 34 patients (10%) developed HAVB within a month post TTVR. Patients who developed HAVB were older (mean age 71.8 ± 13.3 vs 62.9 ± 18.8 years, p=0.01, SD 0.55) and hypertensive (84% VS 63%, p=0.0167, SD 0.50). The prevalence of end-stage renal disease was significantly higher in the HAVB group. Conduction system abnormalities (CSA): first-degree AV block, p=0.0002; left anterior fascicular block, p&lt;0.0001; left bundle branch block, p&lt;0.0001; persistent atrial fibrillation p=0.0112; atrial flutter p&lt;0.0001, were disproportionately higher in the HAVB cohort. Importantly, 60% of patients with HAVB required pacemaker implantation within 30 days compared with 3.8% in the non-HAVB group (Risk Ratio 15.7, 95% CI 7.9–31.2, p&lt;0.001).</div></div><div><h3>Conclusions</h3><div>In this real-world analysis of patients undergoing TTVR, 10% developed HDAVB within 1 month, and the majority required pacemaker implantation. Baseline CSAs emerged as significant risk factors. Large multicenter studies are needed to identify high risk patients in the peri-procedural planning of TTVR.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Page S4"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Downregulation of insulin-like growth factor I (IGF-1) signaling induces cell senescence in vascular smooth muscle cells: implications for atherosclerotic plaque progression 胰岛素样生长因子I (IGF-1)信号的下调诱导血管平滑肌细胞衰老:对动脉粥样硬化斑块进展的影响
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.010
S Sukhanov, Y Higashi, S Danchuk, P Delafontaine

Purpose

IGF-1 is a major growth factor, which promotes cell proliferation, and survival. IGF-1 reduced atherosclerosis in aortas in Apoe-/- mice and in coronaries in hypercholesterolemic pigs (FH pigs). Cell senescence is an irreversible cell proliferation arrest associated with the progression of atherosclerosis, however specific mechanisms linking senescence with atherogenesis remain to be identified.
We hypothesized that IGF1 receptor (IGF1R) downregulation would induce SMC senescence in vitro and that activation of IGF1R signaling would suppress SMC senescence in the atherosclerotic plaque.

Methods

Bleomycin (10ug/ml, 5d)-treated aortic SMC were used as in vitro senescence model. Cell proliferation was assessed with Incucyte live-cell system, senescence markers (γ-H2AX histone and p21) - by IHC, β-galactosidase (βGal) activity – X-gal assay, IGF-1-induced signaling – immunoblotting for pSer473-AKT.

Results

Bleomycin-treated SMC have downregulated IGF1R levels (4.1-fold decrease) and inhibited IGF-1 signaling (8.3-fold reduction) (all are P<0.05 vs. control) indicating that cell senescence inhibits IGF-1 signaling. SMC treatment with 3uM picropodophyllin (IGF1R inhibitor) or with 100nM ganitumab (IGF1R antibody) decreased IGF-1-induced signaling, arrested SMC proliferation and upregulated senescence markers (βGal activity and γ-H2AX expression) showing that specific inhibition of IGF-1 signaling induces cell senescence. To test whether activation of IGF-1 signaling inhibits senescence in plaque cells we used coronary sections obtained from IGF-1 (100μg/kg/d, 180d)-treated or control FH pigs. IGF-1 downregulated senescence markers in the plaque fibrous cap: βGal: 62% decrease, p21: 68% decrease (all are P<0.05 vs. control) and depleted SMC-like senescent cells (βGal+/aSMA+ cells) (19% decrease vs. control). Spatial transcriptomics indicated that coronary plaques from IGF-1-treated pigs have a significantly decreased senescence module score (the average expression of 63 senescence genes relative to random gene list controls) in the plaque fibrous cap.

Conclusions

IGF1R downregulation induced SMC senescence in vitro and activation of IGF1R signaling downregulated senescence markers, and decreased levels of SMC-like senescent cells in the porcine coronary plaque. Our results identified a novel mechanism linking reduced IGF-1 signaling with cell senescence and progression of atherosclerosis and provide a potential novel therapeutic target.
igf -1是促进细胞增殖和存活的主要生长因子。IGF-1可减少Apoe-/-小鼠主动脉动脉粥样硬化和高胆固醇血症猪(FH猪)冠状动脉粥样硬化。细胞衰老是一种与动脉粥样硬化进展相关的不可逆的细胞增殖停滞,然而,将衰老与动脉粥样硬化形成联系起来的具体机制仍有待确定。我们假设IGF1受体(IGF1R)下调会在体外诱导SMC衰老,而IGF1R信号的激活会抑制动脉粥样硬化斑块中SMC的衰老。方法采用博来霉素(10ug/ml, 5d)处理主动脉SMC作为体外衰老模型。用诱导细胞活细胞系统评估细胞增殖,用免疫组化法评估衰老标志物(γ-H2AX组蛋白和p21),用X-gal测定β-半乳糖苷酶(βGal)活性,用igf -1诱导的pSer473-AKT信号免疫印迹法评估细胞增殖。结果博莱霉素处理SMC后,IGF1R水平下调(降低4.1倍),IGF-1信号传导抑制(降低8.3倍)(p < 0.05),表明细胞衰老抑制IGF-1信号传导。用3uM picropodophylin (IGF1R抑制剂)或100nM ganitumab (IGF1R抗体)处理SMC可降低IGF-1诱导的信号,抑制SMC增殖,上调衰老标志物(βGal活性和γ-H2AX表达),表明IGF-1信号的特异性抑制可诱导细胞衰老。为了测试IGF-1信号的激活是否抑制斑块细胞的衰老,我们使用IGF-1 (100μg/kg/d, 180d)处理或对照FH猪的冠状动脉切片。IGF-1下调斑块纤维帽中的衰老标志物:βGal:减少62%,p21:减少68%(与对照组相比均为P<;0.05),并减少smc样衰老细胞(βGal+/aSMA+细胞)(与对照组相比减少19%)。空间转录组学表明,igf -1处理后的猪冠状动脉斑块纤维帽的衰老模块评分(63个衰老基因相对于随机基因表对照的平均表达量)显著降低。结论sigf1r的下调诱导体外SMC衰老,IGF1R信号通路的激活下调衰老标志物,降低了猪冠状动脉斑块中SMC样衰老细胞的水平。我们的研究结果发现了一种将IGF-1信号减少与细胞衰老和动脉粥样硬化进展联系起来的新机制,并提供了一种潜在的新治疗靶点。
{"title":"Downregulation of insulin-like growth factor I (IGF-1) signaling induces cell senescence in vascular smooth muscle cells: implications for atherosclerotic plaque progression","authors":"S Sukhanov,&nbsp;Y Higashi,&nbsp;S Danchuk,&nbsp;P Delafontaine","doi":"10.1016/j.amjms.2025.12.010","DOIUrl":"10.1016/j.amjms.2025.12.010","url":null,"abstract":"<div><h3>Purpose</h3><div>IGF-1 is a major growth factor, which promotes cell proliferation, and survival. IGF-1 reduced atherosclerosis in aortas in Apoe-/- mice and in coronaries in hypercholesterolemic pigs (FH pigs). Cell senescence is an irreversible cell proliferation arrest associated with the progression of atherosclerosis, however specific mechanisms linking senescence with atherogenesis remain to be identified.</div><div>We hypothesized that IGF1 receptor (IGF1R) downregulation would induce SMC senescence <em>in vitro</em> and that activation of IGF1R signaling would suppress SMC senescence in the atherosclerotic plaque.</div></div><div><h3>Methods</h3><div>Bleomycin (10ug/ml, 5d)-treated aortic SMC were used as <em>in vitro</em> senescence model. Cell proliferation was assessed with Incucyte live-cell system, senescence markers (γ-H2AX histone and p21) - by IHC, β-galactosidase (βGal) activity – X-gal assay, IGF-1-induced signaling – immunoblotting for pSer473-AKT.</div></div><div><h3>Results</h3><div>Bleomycin-treated SMC have downregulated IGF1R levels (4.1-fold decrease) and inhibited IGF-1 signaling (8.3-fold reduction) (all are P&lt;0.05 vs. control) indicating that cell senescence inhibits IGF-1 signaling. SMC treatment with 3uM picropodophyllin (IGF1R inhibitor) or with 100nM ganitumab (IGF1R antibody) decreased IGF-1-induced signaling, arrested SMC proliferation and upregulated senescence markers (βGal activity and γ-H2AX expression) showing that specific inhibition of IGF-1 signaling induces cell senescence. To test whether activation of IGF-1 signaling inhibits senescence in plaque cells we used coronary sections obtained from IGF-1 (100μg/kg/d, 180d)-treated or control FH pigs. IGF-1 downregulated senescence markers in the plaque fibrous cap: <em>β</em>Gal: 62% decrease, p21: 68% decrease (all are P&lt;0.05 vs. control) and depleted SMC-like senescent cells (βGal<sup>+</sup>/aSMA<sup>+</sup> cells) (19% decrease vs. control). Spatial transcriptomics indicated that coronary plaques from IGF-1-treated pigs have a significantly decreased senescence module score (the average expression of 63 senescence genes relative to random gene list controls) in the plaque fibrous cap.</div></div><div><h3>Conclusions</h3><div>IGF1R downregulation induced SMC senescence <em>in vitro</em> and activation of IGF1R signaling downregulated senescence markers, and decreased levels of SMC-like senescent cells in the porcine coronary plaque. Our results identified a novel mechanism linking reduced IGF-1 signaling with cell senescence and progression of atherosclerosis and provide a potential novel therapeutic target.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Page S3"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page 标题页
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/S0002-9629(26)00033-9
{"title":"Title Page","authors":"","doi":"10.1016/S0002-9629(26)00033-9","DOIUrl":"10.1016/S0002-9629(26)00033-9","url":null,"abstract":"","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Page ii"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilizing a drug-eluting stent for an iatrogenic coronary artery dissection 利用药物洗脱支架治疗医源性冠状动脉夹层
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 DOI: 10.1016/j.amjms.2025.12.045
J Macaulay, K Williams, M Calico, U Chaudry, A Shukla, S Sanne, N Masri
<div><h3>Case Report</h3><div>Introduction: Coronary artery dissection is a rare but significant non-atherosclerotic cause of acute coronary syndrome, with the potential to progress to fatal vessel occlusion. Dissections can occur spontaneously or iatrogenically, typically following a percutaneous coronary intervention (PCI), where disruption of the coronary intima creates a false lumen between the vessel wall layers. Due to its rarity, there is ongoing debate regarding the optimal treatment strategies.</div></div><div><h3>Case</h3><div>A 66-year-old female with a history of coronary artery disease, status post drug-eluting stents placed in the left anterior descending (LAD) and left circumflex (LCX) arteries, presented one-month post-procedure with acute-onset dyspnea and angina. Laboratory evaluation revealed elevated troponin (1.966 ng/mL) and brain natriuretic peptide (1,400 pg/mL); however, the electrocardiogram showed no acute ischemic changes. The patient was started on dual antiplatelet therapy (DAPT), metoprolol succinate, and losartan, and was promptly taken for coronary angiography. Cardiac catheterization revealed a significant 15 mm edge dissection at the site of the previously placed ostial circumflex stent, extending into the media of the proximal LCX. An everolimus-eluting stent was successfully placed to cover the edge dissection.</div></div><div><h3>Discussion</h3><div>Remote coronary artery dissections post-stenting, although rare, have been documented in medical literature. Case reports, such as one by Dogan et al., illustrate that in-stent dissections can occur even years after stent implantation and may be successfully managed with coronary re-stenting. The American Heart Association has recognized the risk of dissection extension following PCI for spontaneous coronary artery dissection, noting the potential for propagation both upstream and downstream within the stented vessel. As a result, conservative therapy is typically preferred, with revascularization reserved for high-risk cases characterized by ongoing ischemia, significant vessel occlusion, or hemodynamic instability. However, Madhavan et al. highlighted that very-late stent-related major adverse cardiovascular events (MACE) can occur between one- and five-years post-PCI, underscoring the need for long-term vigilance in patients with prior stent placement. In this reported case, the dissection was likely iatrogenic, secondary to the previously placed stent. Given the patient's acute symptoms and significant troponin elevation despite medical management, PCI was pursued due to concerns for further dissection propagation and acute vessel closure. This case contributes to the growing body of evidence on the delayed complications of coronary stenting, such as coronary artery dissection, as seen in this case. The timing of these complications can vary, with dissections occurring anywhere from months to years after stent placement, reinforcing the need for ongoing clinic
病例报告简介:冠状动脉夹层是急性冠状动脉综合征的一种罕见但重要的非动脉粥样硬化性病因,有可能发展为致命的血管闭塞。夹层可自发或医源性发生,通常在经皮冠状动脉介入治疗(PCI)后发生,冠状动脉内膜破裂在血管壁层之间形成假腔。由于其罕见性,关于最佳治疗策略一直存在争议。病例:66岁女性,冠状动脉病史,左前降支(LAD)和左旋支(LCX)药物洗脱支架置入后状态,术后1个月出现急性呼吸困难和心绞痛。实验室检查显示肌钙蛋白升高(1.966 ng/mL),脑钠肽升高(1400 pg/mL);但心电图未见急性缺血性改变。患者开始双重抗血小板治疗(DAPT),琥珀酸美托洛尔和氯沙坦,并立即采取冠状动脉造影。心导管检查显示,在先前放置的口旋支架位置有明显的15mm边缘剥离,延伸到近端LCX的中间。成功放置依维莫司洗脱支架以覆盖边缘夹层。讨论支架置入术后远端冠状动脉剥离,虽然罕见,但在医学文献中有记载。病例报告,如Dogan等人的报告,说明支架内夹层可能在支架植入数年后发生,并且可以通过冠状动脉再支架置入术成功地处理。美国心脏协会已经认识到自发性冠状动脉剥离PCI术后剥离扩展的风险,注意到支架血管在上游和下游的传播潜力。因此,保守治疗通常是首选,对于持续缺血、明显血管闭塞或血流动力学不稳定的高危病例保留血运重建术。然而,Madhavan等人强调,极晚支架相关的主要不良心血管事件(MACE)可能发生在pci术后1 - 5年,这强调了既往支架置入术患者需要长期保持警惕。在这个报告的病例中,夹层可能是医源性的,继发于先前放置的支架。考虑到患者的急性症状和在医疗管理下肌钙蛋白明显升高,由于担心进一步的夹层扩展和急性血管关闭,我们进行了PCI治疗。本病例为冠状动脉支架置入术的迟发性并发症(如冠状动脉夹层)提供了越来越多的证据。这些并发症发生的时间各不相同,在支架放置后数月至数年发生夹层,这加强了对持续临床监测和及时干预晚期不良事件的需求。
{"title":"Utilizing a drug-eluting stent for an iatrogenic coronary artery dissection","authors":"J Macaulay,&nbsp;K Williams,&nbsp;M Calico,&nbsp;U Chaudry,&nbsp;A Shukla,&nbsp;S Sanne,&nbsp;N Masri","doi":"10.1016/j.amjms.2025.12.045","DOIUrl":"10.1016/j.amjms.2025.12.045","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Case Report&lt;/h3&gt;&lt;div&gt;Introduction: Coronary artery dissection is a rare but significant non-atherosclerotic cause of acute coronary syndrome, with the potential to progress to fatal vessel occlusion. Dissections can occur spontaneously or iatrogenically, typically following a percutaneous coronary intervention (PCI), where disruption of the coronary intima creates a false lumen between the vessel wall layers. Due to its rarity, there is ongoing debate regarding the optimal treatment strategies.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Case&lt;/h3&gt;&lt;div&gt;A 66-year-old female with a history of coronary artery disease, status post drug-eluting stents placed in the left anterior descending (LAD) and left circumflex (LCX) arteries, presented one-month post-procedure with acute-onset dyspnea and angina. Laboratory evaluation revealed elevated troponin (1.966 ng/mL) and brain natriuretic peptide (1,400 pg/mL); however, the electrocardiogram showed no acute ischemic changes. The patient was started on dual antiplatelet therapy (DAPT), metoprolol succinate, and losartan, and was promptly taken for coronary angiography. Cardiac catheterization revealed a significant 15 mm edge dissection at the site of the previously placed ostial circumflex stent, extending into the media of the proximal LCX. An everolimus-eluting stent was successfully placed to cover the edge dissection.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Discussion&lt;/h3&gt;&lt;div&gt;Remote coronary artery dissections post-stenting, although rare, have been documented in medical literature. Case reports, such as one by Dogan et al., illustrate that in-stent dissections can occur even years after stent implantation and may be successfully managed with coronary re-stenting. The American Heart Association has recognized the risk of dissection extension following PCI for spontaneous coronary artery dissection, noting the potential for propagation both upstream and downstream within the stented vessel. As a result, conservative therapy is typically preferred, with revascularization reserved for high-risk cases characterized by ongoing ischemia, significant vessel occlusion, or hemodynamic instability. However, Madhavan et al. highlighted that very-late stent-related major adverse cardiovascular events (MACE) can occur between one- and five-years post-PCI, underscoring the need for long-term vigilance in patients with prior stent placement. In this reported case, the dissection was likely iatrogenic, secondary to the previously placed stent. Given the patient's acute symptoms and significant troponin elevation despite medical management, PCI was pursued due to concerns for further dissection propagation and acute vessel closure. This case contributes to the growing body of evidence on the delayed complications of coronary stenting, such as coronary artery dissection, as seen in this case. The timing of these complications can vary, with dissections occurring anywhere from months to years after stent placement, reinforcing the need for ongoing clinic","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 ","pages":"Pages S24-S25"},"PeriodicalIF":1.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146175584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In untreated non-diabetic subjects, obesity is accompanied by greater associations of blood viscosity with glucose and oxidative metabolism 在未经治疗的非糖尿病受试者中,肥胖伴随着血液粘度与葡萄糖和氧化代谢的更大关联。
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.amjms.2025.09.006
Fumihiro Tomoda M.D., Ph.D. , Hiroko Kurosaki M.D., Ph.D. , Hiroko Sugimori M.D., Ph.D. , Tsutomu Koike M.D., Ph.D. , Maiko Ohara M.D., Ph.D. , Atsumi Nitta Ph.D. , Koichiro Kinugawa M.D., Ph.D.

Background

The influences of blood viscosity on metabolism and the peripheral circulation have not been fully explored in obesity. We evaluated the impact of obesity on the associations of blood viscosity with those two systems in non-diabetic subjects.

Methods

In 119 obese and 163 non-obese non-diabetic subjects, blood viscosity was measured using a falling-ball microviscometer. Homeostasis model assessment of insulin resistance (HOMA-IR) and blood lactate were also determined as indices for insulin resistance and anaerobic metabolism, respectively.

Results

Blood viscosity was significantly greater in the obese group than in the non-obese group (4.25±0.46 versus 4.14±0.44 mPa·S, p = 0.032). Blood viscosity was independently positively associated with log HOMA-IR and log blood lactate in the obese group, but not in the non-obese group. In all subjects, the body mass index status (i.e., non-obese or obese = 0 or 1) × blood viscosity interaction was significantly associated with log HOMA-IR and log blood lactate (partial r = 0.130, p = 0.029 and partial r = 0.173, p = 0.013). Thus, greater influences of blood viscosity on glucose and oxidative metabolism were observed in the obese group than the non-obese group. However, only approximately 9 to 11 % of the variance in blood viscosity was attributable to differences in log HOMA-IR or log blood lactate in the obese group. Contrastingly, blood viscosity did not relate with blood pressure in either group.

Conclusions

In non-diabetic obesity, blood viscosity elevates, and such hemorheological change could at least partially contribute to the aggravations of insulin resistance and anaerobic metabolism.
背景:血液黏稠度对肥胖患者代谢和外周循环的影响尚未得到充分探讨。我们评估了肥胖对非糖尿病受试者血液粘度与这两个系统的关联的影响。方法:对119例肥胖患者和163例非肥胖非糖尿病患者采用落球式微粘度计测定血液粘度。胰岛素抵抗的稳态模型评估(HOMA-IR)和血乳酸分别作为胰岛素抵抗和无氧代谢的指标。结果:肥胖组血黏度明显高于非肥胖组(4.25±0.46比4.14±0.44 mPa·S, p= 0.032)。在肥胖组中,血液粘度与对数HOMA-IR和对数血乳酸呈独立正相关,但在非肥胖组中没有。在所有受试者中,身体质量指数状态(即非肥胖或肥胖 = 0或1) × 血液粘度相互作用与对数HOMA-IR和对数血乳酸显著相关(偏r= 0.130, p= 0.029,偏r= 0.173, p= 0.013)。因此,肥胖组的血液粘度对葡萄糖和氧化代谢的影响大于非肥胖组。然而,在肥胖组中,只有大约9%到11%的血液粘度差异可归因于对数HOMA-IR或对数血乳酸的差异。相比之下,两组的血液粘度与血压无关。结论:在非糖尿病性肥胖中,血液黏度升高,这种血液流变学变化至少部分导致胰岛素抵抗和无氧代谢的加重。
{"title":"In untreated non-diabetic subjects, obesity is accompanied by greater associations of blood viscosity with glucose and oxidative metabolism","authors":"Fumihiro Tomoda M.D., Ph.D. ,&nbsp;Hiroko Kurosaki M.D., Ph.D. ,&nbsp;Hiroko Sugimori M.D., Ph.D. ,&nbsp;Tsutomu Koike M.D., Ph.D. ,&nbsp;Maiko Ohara M.D., Ph.D. ,&nbsp;Atsumi Nitta Ph.D. ,&nbsp;Koichiro Kinugawa M.D., Ph.D.","doi":"10.1016/j.amjms.2025.09.006","DOIUrl":"10.1016/j.amjms.2025.09.006","url":null,"abstract":"<div><h3>Background</h3><div>The influences of blood viscosity on metabolism and the peripheral circulation have not been fully explored in obesity. We evaluated the impact of obesity on the associations of blood viscosity with those two systems in non-diabetic subjects.</div></div><div><h3>Methods</h3><div>In 119 obese and 163 non-obese non-diabetic subjects, blood viscosity was measured using a falling-ball microviscometer. Homeostasis model assessment of insulin resistance (HOMA-IR) and blood lactate were also determined as indices for insulin resistance and anaerobic metabolism, respectively.</div></div><div><h3>Results</h3><div>Blood viscosity was significantly greater in the obese group than in the non-obese group (4.25±0.46 versus 4.14±0.44 mPa·S, <em>p</em> = 0.032). Blood viscosity was independently positively associated with log HOMA-IR and log blood lactate in the obese group, but not in the non-obese group. In all subjects, the body mass index status (i.e., non-obese or obese = 0 or 1) × blood viscosity interaction was significantly associated with log HOMA-IR and log blood lactate (partial <em>r</em> = 0.130, <em>p</em> = 0.029 and partial <em>r</em> = 0.173, <em>p</em> = 0.013). Thus, greater influences of blood viscosity on glucose and oxidative metabolism were observed in the obese group than the non-obese group. However, only approximately 9 to 11 % of the variance in blood viscosity was attributable to differences in log HOMA-IR or log blood lactate in the obese group. Contrastingly, blood viscosity did not relate with blood pressure in either group.</div></div><div><h3>Conclusions</h3><div>In non-diabetic obesity, blood viscosity elevates, and such hemorheological change could at least partially contribute to the aggravations of insulin resistance and anaerobic metabolism.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 1","pages":"Pages 23-29"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145042817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cumulative burden of non-medical drivers of health and their associations with hospital utilization 非医疗健康驱动因素累积负担及其与医院利用的关系
IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.amjms.2025.10.014
Jemima C. John Ph.D , Mallika Mathur Ph.D , Shreela V. Sharma Ph.D , Winston Liaw MD , Angela L. Stotts Ph.D , Thomas F. Northrup Ph.D , Thomas J. Murphy MD

Background

Vulnerable populations experience multiple adverse non-medical drivers of health (NMDOH) that contribute to poorer health outcomes and increased healthcare utilization. This cross-sectional study examined the associations between NMDOH and hospital-based outcomes in a 2018 Medical Legal Partnership pilot study.

Methods

Composite scores generated for socio-economic and housing-environmental conditions were categorized to reflect the cumulative burden of unmet needs. Logistic regression models examined associations between these scores and the number of ED visits (≥3 visits in the past year) and Hospital stays (≥2 days in the past year), controlling for age, sex, race, and income.

Results

In this sample of 174 participants (mean age=52.5 years; 68.2 % female; 55 % Black, 28 % Hispanic; and average monthly income =$1,196), 74 % were food insecure, 68.3 % had ≥2 social and economic needs, and 47.6 % reported >1 housing-environmental concern. There were significantly greater odds of ≥3 ED visits (AOR: 7.3; P = 0.003) and similarly greater odds of a Hospital stay of ≥2 days. (AOR: 5.6; P = 0.032) among those with ≥4 vs. <4 personal SDOH needs.

Conclusions

Having ≥4 social and economic conditions was strongly associated with poor hospital-related outcomes, indicating the need for a strong response and targeting of the NMDOH that impact healthcare utilization outcomes.
背景:弱势群体经历多种不利的非医疗健康驱动因素(NMDOH),导致较差的健康结果和增加的医疗保健利用。这项横断面研究在2018年的一项医疗-法律伙伴关系试点研究中研究了NMDOH与医院结果之间的关系。方法:对社会经济和住房环境条件产生的综合得分进行分类,以反映未满足需求的累积负担。Logistic回归模型检验了这些分数与急诊科就诊次数(过去一年≥3次)和住院时间(过去一年≥2天)之间的关系,控制了年龄、性别、种族和收入。结果:在174名参与者(平均年龄为52.5岁,68.2%为女性,55%为黑人,28%为西班牙裔,平均月收入为1196美元)的样本中,74%的人粮食不安全,68.3%的人有≥2个社会和经济需求,47.6%的人报告有1个住房环境问题。就诊≥3次ED的几率显著增加(AOR: 7.3; P=0.003),住院≥2天的几率也显著增加。(AOR: 5.6; P=0.032)结论:拥有≥4个社会和经济条件与较差的医院相关结果密切相关,表明需要对影响医疗保健利用结果的NMDOH作出强有力的反应和目标。
{"title":"Cumulative burden of non-medical drivers of health and their associations with hospital utilization","authors":"Jemima C. John Ph.D ,&nbsp;Mallika Mathur Ph.D ,&nbsp;Shreela V. Sharma Ph.D ,&nbsp;Winston Liaw MD ,&nbsp;Angela L. Stotts Ph.D ,&nbsp;Thomas F. Northrup Ph.D ,&nbsp;Thomas J. Murphy MD","doi":"10.1016/j.amjms.2025.10.014","DOIUrl":"10.1016/j.amjms.2025.10.014","url":null,"abstract":"<div><h3>Background</h3><div>Vulnerable populations experience multiple adverse non-medical drivers of health (NMDOH) that contribute to poorer health outcomes and increased healthcare utilization. This cross-sectional study examined the associations between NMDOH and hospital-based outcomes in a 2018 Medical Legal Partnership pilot study.</div></div><div><h3>Methods</h3><div>Composite scores generated for socio-economic and housing-environmental conditions were categorized to reflect the cumulative burden of unmet needs. Logistic regression models examined associations between these scores and the number of ED visits (≥3 visits in the past year) and Hospital stays (≥2 days in the past year), controlling for age, sex, race, and income.</div></div><div><h3>Results</h3><div>In this sample of 174 participants (mean age=52.5 years; 68.2 % female; 55 % Black, 28 % Hispanic; and average monthly income =$1,196), 74 % were food insecure, 68.3 % had ≥2 social and economic needs, and 47.6 % reported &gt;1 housing-environmental concern. There were significantly greater odds of ≥3 ED visits (AOR: 7.3; <em>P</em> <em>=</em> <em>0.003</em>) and similarly greater odds of a Hospital stay of ≥2 days. (AOR: 5.6; <em>P</em> <em>=</em> <em>0.032</em>) among those with ≥4 vs. &lt;4 personal SDOH needs.</div></div><div><h3>Conclusions</h3><div>Having ≥4 social and economic conditions was strongly associated with poor hospital-related outcomes, indicating the need for a strong response and targeting of the NMDOH that impact healthcare utilization outcomes.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"371 1","pages":"Pages 65-70"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of the Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1